Human Health

What we believe:

Knowledge is power

You can make better choices for managing your health when you gain a basic understanding of the pros and cons of treatment options. We believe that simple, inexpensive options are often the best – but may be neglected or overlooked by researchers, pharmaceutical companies and care providers because of a lack of profit potential and investment.

Our goal:

Improving health with affordable and accessible options

The Parsemus Foundation’s goal is to advance innovative and neglected medical research. We focus on supporting small proof-of-concept studies and then pursuing press coverage of the results, so that the advances change treatment practice rather than disappearing into the scientific literature. Many of the studies we support involve low-cost approaches that are not under patent. From support for new male contraceptives to research on the use of existing medicines to treat COVID-19, the Parsemus Foundation aims to improve human health with affordable and accessible options.

This section of our website provides information on specific medical topics, and includes references and educational links for further study. You’ll also find information on select past projects focused on areas we are no longer pursuing.

Human Health Projects

Doctor checking tube with blood analysis and making notes

Iron Deficiency

Iron deficiency and anemia are common and can result in significant negative health impacts. Intravenous iron offers a rapid treatment option.

Read More
breast cancer prevention

Breast Cancer Prevention

Intraductal methods can provide less invasive options for treatment of ductal carcinoma in situ (DCIS), the most common noninvasive lesion of the breast.

Read More
Fluvoxamine and COVID-19 virus

COVID-19

Simple, inexpensive therapies using existing medicines – like measles vaccine and metformin – are being studied to prevent or treat COVID-19 infection.

Read More

Human Health News

Omega-3 fatty acids may protect brain health

Recent studies highlight the potential role of omega-3 fatty acids in protecting brain health, especially among older adults. These essential fats, found in fatty fish like salmon, offer benefits for heart health, inflammation, and brain function. Now, two studies suggest they may also benefit individuals at higher risk for cognitive decline, such as carriers of the ε4 allele of the apolipoprotein E gene (APOE4).

Read More

Iron deficiency and anemia are hidden ailments in women

Despite the high prevalence of iron deficiency and anemia in women in their reproductive years, it is still widely underdiagnosed and undertreated. Anemia can result in poorer outcomes in pregnancy. Diagnosis involves routine blood tests, and treatment may include diet changes, oral iron supplements, or intravenous iron.

Read More

How Scientists Plan on Eliminating Alzheimer’s Disease

Breakthroughs in Alzheimer’s disease research offer hope for the successful treatment – and elimination – of the disease. This was the finding of New Scientist journalist Graham Lawton, who reviewed the history and status of research on dementia and Alzheimer’s disease. In particular, exciting new Alzheimer’s vaccine research holds promise for preventing Alzheimer’s disease.

Read More

Shingles vaccine may lower dementia risk

The recombinant zoster vaccine known as SHINGRIX may also lower the risk of developing dementia, according to a new study. The vaccine prevents shingles, a painful viral infection, and is typically recommended for those 50 and older. Researchers in the U.K. published a study in Nature Medicine on July 25 that showed that among people diagnosed with dementia, those who received the recombinant zoster vaccine had more diagnosis-free time compared with those who received a different vaccine.

Read More

Cognitive dysfunction syndrome in cats similar to Alzheimer’s disease

House cats live an average of 14 years, and it’s not uncommon for a cat to live more than 20 years. Older cats often develop cognitive decline resulting in dementia. It’s called “cognitive dysfunction syndrome” or CDS. This condition is similar in many ways to Alzheimer’s disease, including amyloid beta and tau protein accumulation. Some believe that environmental stressors from life as a house cat contribute to cognitive decline.

Read More

Ultra-processed foods affect brain health

Recent research has revealed that eating ultra-processed foods affects brain health. Studies suggest that diets high in these foods could increase the risk of cognitive impairment and stroke. Ultra-processed foods include industrially prepared items like packaged snacks, ready-made meals, and sugary drinks. These foods are often convenient, but they carry hidden health dangers.

Read More

Omega-3 fatty acids may protect brain health

Recent studies highlight the potential role of omega-3 fatty acids in protecting brain health, especially among older adults. These essential fats, found in fatty fish like salmon, offer benefits for heart health, inflammation, and brain function. Now, two studies suggest they may also benefit individuals at higher risk for cognitive decline, such as carriers of the ε4 allele of the apolipoprotein E gene (APOE4).

Read More

Iron deficiency and anemia are hidden ailments in women

Despite the high prevalence of iron deficiency and anemia in women in their reproductive years, it is still widely underdiagnosed and undertreated. Anemia can result in poorer outcomes in pregnancy. Diagnosis involves routine blood tests, and treatment may include diet changes, oral iron supplements, or intravenous iron.

Read More

How Scientists Plan on Eliminating Alzheimer’s Disease

Breakthroughs in Alzheimer’s disease research offer hope for the successful treatment – and elimination – of the disease. This was the finding of New Scientist journalist Graham Lawton, who reviewed the history and status of research on dementia and Alzheimer’s disease. In particular, exciting new Alzheimer’s vaccine research holds promise for preventing Alzheimer’s disease.

Read More

Shingles vaccine may lower dementia risk

The recombinant zoster vaccine known as SHINGRIX may also lower the risk of developing dementia, according to a new study. The vaccine prevents shingles, a painful viral infection, and is typically recommended for those 50 and older. Researchers in the U.K. published a study in Nature Medicine on July 25 that showed that among people diagnosed with dementia, those who received the recombinant zoster vaccine had more diagnosis-free time compared with those who received a different vaccine.

Read More
We’re sorry, you are not eligible for the nationwide COVID-OUT or ACTIV-6 studies, but you may be eligible for other federal trials:

And if you don’t find a match there, this slightly more complex clinical trials finder includes studies sponsored by companies as well:

Trials Today